卡格列净治疗2型糖尿病合并心血管高风险患者的安全性及其对相关指标的影响(5)
[20] KALRA S. Sodium-glucose cotransporter 2(SGLT2) inhibitors and cardiovascular disease: a systematic review[J]. Cardiol Ther,2016,5(2):161-168.[21] INZUCCHI SE,ZINMAN B,WANNER C,et al. SGLT-2 inhibitors and cardiovascular risk: proposed pathways and review of ongoing outcome trials[J]. Diab Vasc Dis Res ......
您现在查看是摘要页,全文长 1824 字符。